EPHX2 and Alzheimer disease: Several sEH inhibitor-basedmultitarget compounds have been recently designed to treat inflammationand pain,3,52−54 but their potentialuse against AD and the dual targeting of sEH and AChE have not beenexplored so far, to the best of our knowledge.